177 related articles for article (PubMed ID: 24964616)
1. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
7. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
10. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
[TBL] [Abstract][Full Text] [Related]
11. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
12. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
Xue K; Xu L; Chen S; Ma G; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
[TBL] [Abstract][Full Text] [Related]
14. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 genetic polymorphisms and risk for esophageal cancer: a case-control study in central China.
Yun YX; Wang YP; Wang P; Cui LH; Wang KJ; Zhang JY; Dai LP
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6507-12. PubMed ID: 24377558
[TBL] [Abstract][Full Text] [Related]
18. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population.
Chen S; Xue K; Xu L; Ma G; Wu J
Mutat Res; 2001 Jun; 458(1-2):41-7. PubMed ID: 11406420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
